Philips 2011 Annual Report Download - page 78

6 Sector performance 6.4.1 - 6.4.1
78 Annual Report 2011
6.4.1 Corporate Technologies
Corporate Technologies feeds the innovation pipeline,
enabling its business partners – the three Philips operating
sectors – to create new business options through new
technologies, venturing and intellectual property
development, to improve time-to-market efficiency, and
to increase innovation effectiveness via focused research
and development activities. In addition, Corporate
Technologies opens up new value spaces beyond current
sector scope or focus (Emerging Business Areas, EBAs),
manages the EBA-related R&D portfolio, and creates
synergy for cross-sector initiatives.
Corporate Technologies encompasses Research,
Incubation, Intellectual Property & Standards (IP&S), the
Philips Innovation Campus as well as Philips Innovation
Services. In total, Corporate Technologies employs about
4,200 professionals around the globe.
Corporate Technologies actively participates in ‘Open
Innovation’ through relationships with academic and
industrial partners, as well as via European and regional
projects, in order to improve innovation efficiency and
share the related financial exposure. The High Tech
Campus in Eindhoven (Netherlands), the Philips
Innovation Campus in Bangalore (India), and Research
Shanghai (China), are prime examples of environments
enabling Open Innovation. In this way, we seek to ensure
proximity of innovation activities to growth geographies.
Philips Research is a key innovation partner for Philips’
business sectors. It has three main roles. Firstly, it creates
new technologies and innovations that help to spur the
growth of the Philips businesses. Secondly, it develops
unique intellectual property (IP), which will enable longer-
term business and creates standardization opportunities
for Philips. Lastly, it prepares the ground for the creation
of game-changers and adjacent businesses in the sectors
based on technology-enabled innovation in strategically
aligned application areas.
On January 1, 2011, innovation competencies of the
former Applied Technologies were merged with those of
Philips Research. The role of the new Research
organization is to co-create and co-develop meaningful
innovations, including the relevant IP, for the Philips
businesses’ current and new business areas and key
markets. The labs in Shanghai and Bangalore focus on
local-for-local innovation, supported by key competencies
and technologies from the laboratories elsewhere.
Outside-in Open Innovation, leveraging the global
network of innovation partners, is an important guiding
principle for Research.
In 2011, Philips Research, in cooperation with Eindhoven
University of Technology, achieved an important
development in MRI-guided local drug delivery for cancer
treatment. The joint team demonstrated in pre-clinical
studies that an improved local drug uptake in tumors is
achieved, and that it can be visualized and measured in real
time. These measurements may give an indication at time
of delivery if drug uptake in the tumor was sufficient, or
if an additional treatment may be needed.
Building upon Philips’ ambient intelligence insights and in-
depth understanding of the hospital patient experience,
Philips Research opened a Hospital Lab to investigate the
effects of healing environments (e.g. lighting, sound,
projection) on the treatment and well-being of patients.
Philips applies the concepts of Incubation and Emerging
Business Areas to new business creation to create
strategic growth opportunities for Philips. In some cases,
spin-out or technology licensing is considered. The Philips
Healthcare Incubator has introduced Digital Pathology
solutions to ease the workload and support decision-
making in central and hospital-based pathology
departments. Through its Handheld Diagnostic venture,
the Healthcare Incubator has set up a number of strategic
partnerships to bring unique point-of-care (PoC)
diagnostic solutions to the market. The most prominent
partnership announced so far is with bioMérieux, on acute
cardiac PoC diagnostics. In addition, the Healthcare
Incubator manages Philips’ investment/relationship with
the healthcare venture capital fund Gilde Healthcare III, in
which Philips made an anchor investment.
CityTouch is an activity that started in the Lighting and
Cleantech Incubator and has now been launched by Philips
Lighting. It is an online intelligent street lighting
management system that enables savings of up to 70% in
energy use and maintenance costs compared to
conventional lighting. Another venture initiated in the
Incubator and now being marketed by Philips Lighting is
the revolutionary lighting concept of Philips luminous
textiles, which bring interior spaces to life with light,
texture and dynamic content. Luminous textiles are an
easy-fit system that integrates multi-colored LED modules
within acoustic textile panels to show dynamic content
and soften sound.
Philips IP&S proactively pursues the creation of new
intellectual property in close co-operation with Philips’
operating sectors and the other departments within
Corporate Technologies. IP&S is a leading industrial IP
organization providing world-class IP solutions to Philips’
businesses to support their growth, competitiveness and
profitability. Philips’ IP portfolio currently consists of